0001193125-11-332854.txt : 20111207 0001193125-11-332854.hdr.sgml : 20111207 20111207081654 ACCESSION NUMBER: 0001193125-11-332854 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20111207 DATE AS OF CHANGE: 20111207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORONADO BIOSCIENCES INC CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 111247157 BUSINESS ADDRESS: STREET 1: 45 ROCKEFELLER PLAZA STREET 2: SUITE 2000 CITY: NEW YORK STATE: NY ZIP: 10111 BUSINESS PHONE: 212-332-1665 MAIL ADDRESS: STREET 1: 45 ROCKEFELLER PLAZA STREET 2: SUITE 2000 CITY: NEW YORK STATE: NY ZIP: 10111 8-A12B 1 d266679d8a12b.htm FORM 8-A FORM 8-A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

CORONADO BIOSCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

  

20-5157386

(State of incorporation

or organization)

  

(I.R.S. Employer

Identification No.)

 

15 New England Executive Park, Burlington, MA

  

01803

(Address of principal executive offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be so registered

  

Name of each exchange on which each class is to be registered

Common Stock, par value $0.001 per share (“Common Stock”)   The NASDAQ Stock Market LLC

If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.  x

If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  ¨

Securities Act registration statement file number to which this form relates: Not Applicable

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

The description of the Common Stock of Coronado Biosciences, Inc. (the “Registrant”), is included under the caption “Description of Securities” in the Prospectus as part of the Registration Statement on Form S-1, as amended (Registration No. 333-177041) (the “Registration Statement”), filed under the Securities Act of 1933, as amended, and is incorporated by reference herein. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that are subsequently filed are hereby also incorporated by reference herein.

 

Item 2. Exhibits.

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Exchange Act.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

    CORONADO BIOSCIENCES, INC.
Date: December 7, 2011     By:   /s/ Dale Ritter
      Name: Dale Ritter
      Title: Senior Vice President, Finance

 

 

3